Progel Vascular Sealant

NACompletedINTERVENTIONAL
Enrollment

158

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Aortic Valve StenosisAneurysm of Ascending AortaAortic Valve DisorderBicuspid Valve Disorder
Interventions
DEVICE

Progel Vascular Sealant

DEVICE

Gelfoam Plus

Trial Locations (19)

10021

Cornell University, New York

10467

Montefiore Medical Center, The Bronx

19104

University of Pennsylvania, Philadelphia

22904

University of Virginia Health Sciences Center, Charlottesville

23298

Virginia Commonwealth University Medical Center, Richmond

28203

Carolinas Health Care System, Charlotte

32610

University of Florida, Gainesville

43214

Ohio Health Research Institute, Columbus

48109

University of Michigan, Ann Arbor

55905

Mayo Clinic Hospital, Rochester

60611

Northwestern University, Chicago

63110

Washington University, St Louis

68510

Bryan Heart, Lincoln

75093

The Heart Hospital Baylor, Plano

77030

Houston Methodist Hospital, Houston

80045

University of Colorado, Aurora

83201

Portneuf Hospital, Pocatello

84107

Intermountain Medical Center, Murray

90048

Cedars-Sinai, Los Angeles

Sponsors

Lead Sponsor

All Listed Sponsors
lead

C. R. Bard

INDUSTRY

NCT01959503 - Progel Vascular Sealant | Biotech Hunter | Biotech Hunter